tegafur has been researched along with Weight Reduction in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized Phase III trial will evaluate whether perioperative nutrition enriched with eicosapentaenoic acid can prevent body weight loss after total gastrectomy for gastric cancer." | 9.16 | A Phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer. ( Cho, H; Fukushima, R; Hiki, N; Morita, S; Nunobe, S; Sano, T; Taguri, M; Taniguchi, H; Tsuburaya, A; Yoshikawa, T, 2012) |
| "This randomized Phase III trial will evaluate whether perioperative nutrition enriched with eicosapentaenoic acid can prevent body weight loss after total gastrectomy for gastric cancer." | 5.16 | A Phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer. ( Cho, H; Fukushima, R; Hiki, N; Morita, S; Nunobe, S; Sano, T; Taguri, M; Taniguchi, H; Tsuburaya, A; Yoshikawa, T, 2012) |
| "Deleterious oral mucositis (OM) develops during radiotherapy (RT) or chemoradiotherapy for head-and-neck cancer (HNC) patients." | 2.77 | Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. ( Chung, YL; Jen, YM; Lin, YH; Wang, LW; Yen, SH, 2012) |
| "Fifty-four patients with resected pancreatic cancer were enrolled." | 1.51 | Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer. ( Furuhashi, S; Hiraide, T; Kikuchi, H; Kitajima, R; Kiuchi, R; Konno, H; Morita, Y; Sakaguchi, T; Shibasaki, Y; Takeda, M; Takeuchi, H, 2019) |
| "Body weight loss is a common outcome in patients with gastric cancer who have undergone gastrectomy." | 1.38 | [Comparison of body weight loss in gastrectomy patients who underwent only surgery and those who underwent surgery followed up with S-1 adjuvant chemotherapy]. ( Aoyama, T; Cho, H; Hayashi, T; Kitani, Y; Masuda, M; Ogata, T; Oshima, T; Ozawa, Y; Rino, Y; Shirai, J; Tsuburaya, A; Wada, H; Yoshikawa, T; Yukawa, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, Y | 1 |
| Sakaguchi, T | 1 |
| Kitajima, R | 1 |
| Furuhashi, S | 1 |
| Kiuchi, R | 1 |
| Takeda, M | 1 |
| Hiraide, T | 1 |
| Shibasaki, Y | 1 |
| Kikuchi, H | 1 |
| Konno, H | 1 |
| Takeuchi, H | 1 |
| Aoyama, T | 4 |
| Hayashi, T | 4 |
| Fujikawa, H | 1 |
| Ogata, T | 3 |
| Cho, H | 5 |
| Wada, H | 2 |
| Kitani, Y | 2 |
| Yukawa, N | 4 |
| Oshima, T | 4 |
| Rino, Y | 4 |
| Ozawa, Y | 2 |
| Masuda, M | 4 |
| Yoshikawa, T | 5 |
| Sato, T | 1 |
| Maezawa, Y | 1 |
| Kano, K | 1 |
| Yamada, T | 2 |
| Yen, SH | 1 |
| Wang, LW | 1 |
| Lin, YH | 1 |
| Jen, YM | 1 |
| Chung, YL | 1 |
| Hiki, N | 1 |
| Taguri, M | 1 |
| Sano, T | 1 |
| Nunobe, S | 1 |
| Taniguchi, H | 1 |
| Fukushima, R | 1 |
| Morita, S | 1 |
| Tsuburaya, A | 3 |
| Shirai, J | 2 |
| Tsuchida, K | 1 |
| Hasegawa, S | 1 |
| Nakano, GI | 1 |
| Katoh, H | 1 |
| Ikeda, H | 1 |
| Sakamoto, K | 1 |
| Nagamachi, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Postoperative Supplemental Parenteral Nutrition (SPN) in Gastric Cancer Patients Who Underwent Gastrectomy: A Multicenter Prospective Randomized Controlled Trial[NCT04607057] | Phase 4 | 224 participants (Anticipated) | Interventional | 2020-12-22 | Recruiting | ||
| Effect of Exercise and Enteral Nutrition Intervention on Survival in Patients With Locally Advanced Gastric Cancer: a Prospective Multicenter Randomized Controlled Study[NCT05959226] | 960 participants (Anticipated) | Interventional | 2023-08-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for tegafur and Weight Reduction
| Article | Year |
|---|---|
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Double-Blind Method; E | 2012 |
A Phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer.
Topics: Adult; Aged; Anastomosis, Roux-en-Y; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Dietar | 2012 |
6 other studies available for tegafur and Weight Reduction
| Article | Year |
|---|---|
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer.
Topics: Aged; Chemotherapy, Adjuvant; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Logisti | 2019 |
[Effect of enteral nutrition enriched with eicosapentaenoic acid on body weight loss and compliance with S-1 adjuvant chemotherapy after gastric cancer surgery].
Topics: Chemotherapy, Adjuvant; Drug Combinations; Eicosapentaenoic Acid; Enteral Nutrition; Female; Gastrec | 2013 |
Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up | 2017 |
Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up | 2017 |
Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up | 2017 |
Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up | 2017 |
Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2013 |
[Comparison of body weight loss in gastrectomy patients who underwent only surgery and those who underwent surgery followed up with S-1 adjuvant chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Human | 2012 |
[Experimental study on combination chemotherapy of UFT and calcium antagonist in gastric cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Drug Screening Assays, Antit | 1989 |